Brii Biosciences Limited, with a market cap of HK$872.45 million, is currently unprofitable and pre-revenue, generating CN¥38.38 million from its biotechnology startups segment.

2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Stock Radar: Maruti Suzuki, Hyundai Motor, Escorts, Cipla, Home First Finance, Aster DM, DLF, Greaves Cotton in focus on Monday Dec 02 2024 12:38 AM Gujarat Natural Consolidated June 2024 Net ...

Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March 1982 as a Private Limited Company and was converted into a Public Limited Company in May 1992. Head quartered ...

Amerise Biosciences Limited (Formerly known Amradeep Industries Limited) was incorporated in 1984 by a private Indian party as a specialized manufacturer of high quality construction equipment and ...

Kimia Biosciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 213.38 Crore) operating in Pharmaceuticals sector. Kimia Biosciences Ltd. key Products/Revenue ...

Drilling at Godolphin’s Lewis Ponds project has delivered outstanding results including 49.6m at 3.53g/t gold equivalent from 210m including 28.2m at 5.76g/t AuEq. This result was returned from one of ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

DiveWire guarantees visibility for your news announcements through instant distribution to HR Dive’s audience and its 240,000 newsletter subscribers for 21 days.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...